NCT03909360 is a NA clinical trial of drainage tube in Cholecystitis, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

Who is sponsoring NCT03909360?

NCT03909360 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

What drugs are being tested in NCT03909360?

Interventions in NCT03909360: drainage tube.

What condition does NCT03909360 study?

NCT03909360 studies Cholecystitis, Cholecystolithiasis, Polyps Gallbladder, Adenomyosis of Gallbladder.

Is NCT03909360 still recruiting?

NCT03909360 is currently status unknown. Last updated 16 April 2019.

Last reviewed 2019-04-16 · How we verify

NCT03909360

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Drainage or Not for Laparoscopic Cholecystetomy

Status unknown NA Last updated 16 April 2019

What this trial tests

NA trial testing drainage tube in Cholecystitis in 200 participants. Status unknown.

Timeline

14 March 2019

Primary endpoint
1 March 2020

1 March 2020

Quick facts

Lead sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	quadruple
Primary purpose	treatment
Enrollment	200
Start date	14 March 2019
Primary completion	1 March 2020
Estimated completion	1 March 2020
Sites	1 location across China

Drugs / interventions tested

drainage tube

Conditions studied

Cholecystitis — all drugs for Cholecystitis →
Cholecystolithiasis — all drugs for Cholecystolithiasis →
Polyps Gallbladder — all drugs for Polyps Gallbladder →
Adenomyosis of Gallbladder — all drugs for Adenomyosis of Gallbladder →

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

Adults 18 to 75, any sex, with Cholecystitis or Cholecystolithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgeons usually choosing drainage tube for laparoscopic cholecystectomy according to their experiences but not guidelines. The investigators design a RCT to evaluate the role of drainage in LC surgery and compare the clinical results between drainage and no drainage.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of no drainage after elective day-case laparoscopic cholecystectomy, even with intraoperative gallbladder perforation: a randomized controlled trial.
Zhu H, Liu D, Zhou D, Wu J, et al · · 2023 · cited 2× · PMID 36856748 · DOI 10.1007/s00423-023-02846-z

Verify or expand the search:

Other recruiting trials for Cholecystitis

Currently open trials in the same condition.

NCT07473687 — Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room · recruiting
NCT07222527 — One vs. Two Stents for Gallbladder Disease · NA · recruiting
NCT06656299 — EOIB for Laparoscopic Cholecystectomy · NA · recruiting
NCT06740903 — Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy · Phase 2, PHASE3 · recruiting
NCT06502028 — Video Laryngeal Mask Versus Endotracheal Tube Undergoing Laparoscopic Cholecystectomy Surgery · NA · recruiting

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03909360 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
Last refreshed: 16 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03909360.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing